---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-033233"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2023-07-17T23:59:59+00:00"
generated_at: "2026-06-13T07:50:38.097249+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Renalytix repays $1.06M of convertible bond via ADS issuance; principal reduced to $15.9M

## Summary
- Repaid $1.06M of convertible bond by issuing 526,211 American Depositary Shares (1,052,422 ordinary shares).
- Remaining principal under the convertible bond after settlement is $15.90M.
- New ordinary shares admitted to trading on AIM effective July 19, 2023.
- Post-admission total ordinary shares outstanding: 94,833,900.
- Announcement corrects prior figure for principal remaining from earlier release.

## SEC filing metadata
- accession: 0000950170-23-033233
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2023-07-17T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000095017023033233/0000950170-23-033233-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000095017023033233/rnlx-20230717.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-033233
- JSON: https://secwatch.observer/filing/0000950170-23-033233.json
- Plain text: https://secwatch.observer/filing/0000950170-23-033233.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.